Comparison 31. Oral immunosuppressants: oral azathioprine with topical clobetasol propionate versus topical clobetasol propionate.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Primary: percentage of participants with investigator‐rated good/excellent control	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
1.1 Week 8	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
1.2 Week 24	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
2 Secondary: investigator‐rated reduction in severity (bigger reduction in severity = better outcome)	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
2.1 Week 4	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
2.2 Week 8	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
2.3 Week 12	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
2.4 Week 24	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
3 Secondary: participant‐rated reduction in severity (bigger reduction in severity = better outcome)	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
3.1 Week 4	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
3.2 Week 8	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
3.3 Week 12	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
3.4 Week 24	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]